Submit Manuscript  

Article Details


Ticagrelor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways

Author(s):

Hanaa Wanas*, Zeinab El Shereef, Laila Rashed and Basma Emad Aboulhoda   Pages 1 - 12 ( 12 )

Abstract:


Background: Idiopathic pulmonary fibrosis (IPF) is a serious disease with high mortality rate. Activation of transforming growth factor (TGF)-β1 production and signalling is considered the corner stone in the epithelial-mesenchymal transition (EMT) process. EMT plays a central role in development of fibrosis in many organs including the lungs. Activated platelets are an important source of TGF-β1 and play a pivotal role in EMT and fibrosis process. The antiplatelet, ticagrelor was previously found to inhibit the EMT in different types of cancer cells, but its ability to serve as an anti-pulmonary fibrosis (PF) agent was not previously investigated.

Objective: In this study, we aim to investigate the potential ability of ticagrelor to ameliorate bleomycin-induced fibrosis in rats.

Methods: PF was induced in rats by intratracheal BLM at a dose of 3 mg/kg. The effect of daily daily 20 mg/kg oral ticagrelor on different histological and biochemical parameters of fibrosis was investigated.

Results: Our results revealed that ticagrelor can alleviate lung fibrosis. We found that ticagrelor inhibited TGF-β1 production and suppressed Smad3 activation and signaling pathway with subsequent inhibition of Slug and Snail. In addition, ticagrelor antagonized PI3K/AKT/mTOR pathway signaling. Moreover, ticagrelor inhibited the EMT that revealed by its ability to up-regulate the epithelial markers as E-cadherin (E-cad) and to decrease the expression of the mesenchymal markers as vimentin (VIM) and alpha-smooth muscle actin (α-SMA).

Conclusion: Our results suggest that the P2Y12 inhibitor, ticagrelor may have a therapeutic potential in reducing the progression of PF.

Keywords:

Lung fibrosis, ticagrelor, bleomycin, TGF-β1, epithelial-mesenchymal transition, platelets

Affiliation:

Departments of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, , Departments of Histopathology, Faculty of Medicine, Cairo University, Cairo, , Departments of Biochemistry, Faculty of Medicine, Cairo University, Cairo, , Department of Anatomy and Embryology, Faculty of medicine, Cairo University, Cairo



Read Full-Text article